Real-world biologics response and super-response in the International Severe Asthma Registry cohort

- Denton, Eve, Hew, Mark, Larenas-Linnemann, Désirée, Murray, Ruth, Celis-Preciado, Carlos Andrés, Al-Lehebi, Riyad, Belhassen, Manon, Bhutani, Mohit, Bosnic-Anticevich, Sinthia Z., Bourdin, Arnaud, Brusselle, Guy G., Busby, John, Peters, Matthew J., Canonica, Giorgio Walter, Heffler, E, Chapman, KR, Charriot, J, Christoff, GC, Chung, LP, Cosio, BG, Côté, A, Costello, RW, Cushen, B, Upham, John W., Fingleton, J, Fonseca, JA, Gibson, Peter G., Heaney, LG, Huang, EW-C, Iwanaga, T, Jackson, DJ, Koh, MS, Lehtimäki, L, Máspero, J, Bulathsinhala, Lakmini, Mahboub, B, Menzies-Gow, AN, Mitchell, PD, Papadopoulos, NG, Papaioannou, AI, Perez-de-Llano, L, Perng, D-W, Pfeffer, PE, Popov, TA, Porsbjerg, CM, Tran, Trung N., Rhee, CK, Roche, N, Sadatsafavi, M, Salvi, S, Schmid, JM, Sheu, C-C, Sirena, C, Torres-Duque, CA, Salameh, L, Patel, PH, Martin, Neil, Ulrik, CS, Wang, E, Wechsler, ME, Price, DB, ISAR LUMINANT Working Group,, Bergeron, Celine, Al-Ahmad, Mona, Altraja, Alan

Impact of initiatinG bioLogics In patients with severe asThma on long-Term OCS or frEquent Rescue steroids (GLITTER): data from the International Severe Asthma Registry

- Chen, Wenjia, Tran, Trung N., Alacqua, Marianna, Al-Ahmad, Mona, Altraja, Alan, Al-Lehebi, Riyad, Bhutani, Mohit, Bjermer, Leif, Bjerrum, Anne-Sofie, Bourdin, Arnaud, von Bülow, Anna, Busby, John, Sadatsafavi, Mohsen, Walter Canonica, Giorgio, Carter, V, Christoff, GC, Cosio, BG, Costello, RW, Fonseca, JA, Gibson, Peter G., Yoo, K-H, Heaney, LG, Heffler, E, Murray, Ruth, Hew, M, Hilberg, O, Hoyte, F, Iwanaga, T, Jackson, DJ, Jones, RC, Koh, MS, Kuna, P, Larenas-Linnemann, D, Lehmann, S, Wong, Nigel Chong Boon, Lehtimäki, L, Lyu, J, Mahboub, B, Maspero, J, Menzies-Gow, AN, Newell, A, Sirena, C, Papadopoulos, NG, Papaioannou, AI, Perez-de-Llano, L, Ali, Nasloon, Perng Steve, D-W, Peters, M, Pfeffer, PE, Porsbjerg, CM, Popov, TA, Rhee, CK, Salvi, S, Taillé, C, Taube, C, Torres-Duque, CA, Ariti, Con, Ulrik, C, Ra, S-W, Wang, E, Wechsler, ME, Price, DB, Bulathsinhala, Lakmini, Gil, Esther Garcia, FitzGerald, J. Mark

Potential severe asthma hidden in UK primary care

- Ryan, Dermot, Heatley, Heath, Heaney, Liam G., Jackson, David J., Pfeffer, Paul E., Busby, John, Menzies-Gow, Andrew N., Jones, Rupert, Tran, Trung N., Al-Ahmad, Mona, Backer, Vibeke, Belhassen, Manon, Bosnic-Anticevich, Sinthia, Bourdin, Arnaud, Bulathsinhala, Lakmini, Carter, Victoria, Chaudhry, Isha, Eleangovan, Neva, FitzGerald, J. Mark, Gibson, Peter G., Hosseini, Naeimeh, Kaplan, Alan, Murray, Ruth B., Rhee, Chin Kook, Van Ganse, Eric, Price, David B.

Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma

- Khatri, Sumita, Moore, Wendy, Gibson, Peter G., Leigh, Richard, Bourdin, Arnaud, Maspero, Jorge, Barros, Manuel, Buhl, Roland, Howarth, Peter, Albers, Frank C., Bradford, Eric S., Gilson, Martyn, Price, Robert G., Yancey, Stephen W., Ortega, Hector